Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

5.3%

1 terminated out of 19 trials

Success Rate

91.7%

+5.2% vs benchmark

Late-Stage Pipeline

5%

1 trials in Phase 3/4

Results Transparency

18%

2 of 11 completed with results

Key Signals

2 with results92% success

Data Visualizations

Phase Distribution

15Total
Not Applicable (9)
Early P 1 (1)
P 1 (1)
P 2 (3)
P 3 (1)

Trial Status

Completed11
Unknown4
Not Yet Recruiting1
Recruiting1
Withdrawn1
Terminated1

Trial Success Rate

91.7%

Benchmark: 86.5%

Based on 11 completed trials

Clinical Trials (19)

Showing 19 of 19 trials
NCT07486531CompletedPrimary

Iron Accumulation in Erythrocytes in Patients

NCT07153926Completed

Elastography vs Iron Regulators in the Diagnosis of Hepatic Fibrosis- Iron Overload in Children With Beta- Thalassemia

NCT06980662Not ApplicableNot Yet RecruitingPrimary

The Effect of Laughter Yoga in Beta Thalassaemia Major Patients: a Randomised Controlled Trial

NCT06831799Completed

ERN-EuroBloodNet Registry on Patients With Rare Red Blood Cell Defects and COVID-19

NCT04776850Early Phase 1WithdrawnPrimary

Pre-transplant Immunosuppression and Donor Stem Cell Transplant for the Treatment of Severe Hemoglobinopathies

NCT06466304Not ApplicableRecruitingPrimary

Inspiratory Muscle Training in Children With Beta Thalasemia

NCT01571635Phase 2TerminatedPrimary

Study to Determine the Safety and Tolerability of Sotatercept (ACE-011) in Adults With Beta( β)- Thalassemia.

NCT04353986Phase 3Unknown

PK of SOF/LED in HCV - Infected Adolescents With Haematological Disorders

NCT04092205Phase 2CompletedPrimary

Phase 2a Pilot Study of NBMI Treatment in Patients With Beta Thalassemia Major, Requiring Iron Chelation

NCT03947632CompletedPrimary

Anthropometric Measurements in Children Having Transfusion-dependent Beta Thalassemia

NCT02744547Not ApplicableCompletedPrimary

Effect of Spirulina on Serum Hyaluronic Acid in Beta Thalassemic Children With Hepatitis C

NCT02744560Not ApplicableCompletedPrimary

Effect of Spirulina on Liver Iron Concentration in Beta Thalassemic Children With Hepatitis C

NCT02744105Not ApplicableCompletedPrimary

Effect of Spirulina on Liver Fibrosis by Transient Elastography in Beta Thalassemic Children With Hepatitis C

NCT03101423Not ApplicableUnknownPrimary

Monitoring of Chimerism After Transplantation in Patients With β Thalassemia Major and the Treatment Strategies for the Reduction of Chimerism

NCT02671695Not ApplicableCompletedPrimary

Effect of Spirulina Compared to Amlodipine on Cardiac Iron Overload in Children With Beta Thalassemia

NCT02674607Not ApplicableCompletedPrimary

the Potential Immunomodulatory Effects of Spirulina on Thalassemic Children

NCT03276455Phase 1UnknownPrimary

Gene Therapy for Beta-Thalassemia Major Using Autologous Hematopoietic Stem Cell Genetically Modified

NCT00658385Not ApplicableCompletedPrimary

Assess the Feasibility and Safety of Granulocyte Colony Stimulating Factor (GCSF) Mobilization of CD34+ Hematopoietic Progenitor Cells in Patients With Betathalassemia Major

NCT02173951Phase 2UnknownPrimary

An Algorithm to Start Iron Chelation in Minimally Transfused Young Beta-thalassemia Major Patients

Showing all 19 trials

Research Network

Activity Timeline